💨 Abstract

Emergency room visits for tick bites are at a five-year high, prompting a new test for Lyme disease. Traditional tests are often inaccurate in the early stages of infection. ACES Diagnostics is developing "LymeSeek," an AI-based test that aims to provide earlier and more accurate detection. The current approach relies on the same 10 antigens used for decades, while LymeSeek targets different antibodies. Early detection is crucial for timely antibiotic treatment and preventing long-term complications.

Courtesy: Scott Gelman